NIH-funded research R01 grant

How sleep and your body clock affect cravings and emotions during opioid medication treatment

Official title: Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation

Funded at Emma Pendleton Bradley Hospital · NIH-11175440 · Data updated 2026-11-12

This work looks at how sleep patterns and circadian rhythms relate to cravings and emotion control in people taking medications for opioid use disorder.

More Emotion Regulation research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmma Pendleton Bradley Hospital
NIH-funded
Lab location1 site (Riverside, UNITED STATES)
Project startSeptember 30, 2023
Project endAugust 31, 2027
Funding year2025
Award (this year)$1,023,443
NIH project number5R01DA059469-03
Project IDNIH-11175440 on NIH RePORTER

Who could benefit from this research

Could help

Adults currently receiving opioid agonist medications (such as methadone or buprenorphine), especially those with sleep problems or difficulty controlling cravings or emotions, are ideal candidates.

Less likely to help

People not on opioid agonist treatment or whose relapse risk is unrelated to sleep or circadian issues are unlikely to benefit directly from this work.

What this research studies

If you are taking methadone or buprenorphine, researchers will measure your sleep patterns, body-clock timing, cravings, and emotion control over time. They will use wearable sleep trackers and lab-based sleep measurements alongside cognitive tests and questionnaires to map sleep architecture and circadian rhythms. The team will compare people on different opioid agonist medications to see whether sleep problems come from shifts in the circadian clock or from changes in sleep structure. Results will help point to specific add-on treatments—such as cognitive behavioral therapy for insomnia—that match your particular sleep disruption.

Why it matters

Potential benefit: If successful, this could lead to personalized sleep-focused treatments that reduce cravings and improve recovery for people on opioid medications.

How similar studies have gone: Previous studies link sleep problems to worse addiction outcomes, but using detailed circadian and sleep-architecture measures to guide targeted treatments is a newer approach.

Where this research is happening

  • Emma Pendleton Bradley Hospital
    Riverside, United States
    Active

Researchers

  • Principal investigator: Carskadon, Mary a — Emma Pendleton Bradley Hospital
  • Study coordinator: Carskadon, Mary a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.